Hoth Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Hoth Therapeutics is registering for the resale of up to 5,030,000 shares of common stock by selling stockholders, potentially generating $9.49 million in gross proceeds upon warrant exercises.